« All Blogs Jan 10, 2020
Key Takeaways from CoC Educational Summit Part 2: CoC Accreditation Standards
CoC Accreditation Standards

CHAMPS Oncology was among the attendees at the CoC Educational Summit: 2020 A Glimpse Into the Future, that took place in Rosemont, IL Nov. 21 through Nov. 22. Last week I shared part one of the key takeaways we received from the CoC Educational Summit. This week I will dive into part two of updates to the CoC accreditation Standards.

CHAMPS Oncology is ready to help cancer programs navigate these changes to the CoC accreditation Standards and will be hosting our first Annual Meeting: 2020 Cancer Program Insights, on January 29, 2019 in Cleveland, Ohio. For more information and to register for the in-person event, click here. If you can't attend in person a downloadable version and CEs will be available for purchase.

Standard 4.1

  • There are specific requirements for Standard 4.1-Physician Credentials. They must be certified through ABMS or AOA, or have 12 cancer-related CMEs each calendar year. This includes all physicians caring for patients with cancer at the accredited facility for at least one calendar year. There are no longer restrictions as to how many CMEs can be earned from the facility and attendance at tumor conferences that are CME-approved now qualify.

Standard 5.1

  • CAP Synoptic Reporting now must meet a 90% score. There will be additional training for site visit reviewers for compliance.

Standard 5.2

  • Quite a bit of time was spent on Standard 5.2. Psychosocial Distress Screening was further defined as needing screenings at least once during the first course of treatment. They made mention that this standard does NOT state “all” patients and it can be performed by a physician, nurse, navigator, etc. Programs should be prepared to have a target number for this standard in their Policy & Procedure and anything above a “4” is recommended to have a face-to-face follow up, whether that is by conference call, telemedicine, etc. (should be something more than a letter). The annual summary must include the following: number of patients screened, number of patients referred for distress resources or further follow up, where patients were referred (on-site or by referral).

Standard 6.1

  • Cancer registry quality control is required to have an annual policy and procedure that defines the procedures to monitor and evaluate each required component. CTRs cannot review their own cases, but a CTR, APRN, PA and/or physician can participate in the case review, along with use of external audits form the state or central registry. They recommended using a grid for this Standard as best practice. N.B. – while 2019 data is preferred, it was stated that 2018 is still acceptable for the time being.

Interested in learning how CHAMPS Oncology can help your cancer program navigate the CoC accreditation Standards? Contact us and check back soon for part three of this series!

« Previous Blog Post Meet January’s Registry Rock Star: Linda
Next Blog Post » Key Takeaways from CoC Educational Summit
About the Author

Amanda Harvey-McKee, BA, CTR

Amanda Harvey McKee

16+ Years of Healthcare Experience

ASK ME ABOUT | Cancer Registry Management, Casefinding, Cancer Committee, Data Completion, Customer Service, Client Implementation

See other articles by this author and view full bio »